We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint | 
Jonathan Silver, MD, MBA
JAMA. 2014;312(1):23-24. doi:10.1001/jama.2014.6672.

Viewpoint | 
Rahul K. Nayak, BSE; Steven D. Pearson, MD, MSc; Franklin G. Miller, PhD
JAMA. 2014;311(15):1491-1492. doi:10.1001/jama.2014.1821.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(12):1217. doi:10.1001/jama.2013.278516.

Original Contribution |  FREE
The Age-Related Eye Disease Study 2 (AREDS2) Research Group*
JAMA. 2013;309(19):2005-2015. doi:10.1001/jama.2013.4997.
Includes: Supplemental Content

Original Contribution |  FREE
Barbara E. K. Klein, MD, MPH; Kerri P. Howard, MS; Ronald E. Gangnon, PhD; et al.
JAMA. 2012;308(23):2469-2478. doi:10.1001/jama.2012.65406.
Includes: Supplemental Content

From the Food and Drug Administration | 
Jane E. Henney, MD
JAMA. 2000;283(21):2779. doi:10.1001/jama.283.21.2779-JFD00004-2-1.

Medical News & Perspectives | 
Rebecca Voelker
JAMA. 1999;282(18):1711-1712. doi:10.1001/jama.282.18.1711-JMN1110-3-1.

Health Agencies Update | 
Joan Stephenson, PhD
JAMA. 1999;282(7):625. doi:10.1001/jama.282.7.625-JHA90006-2-1.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Invited Commentary  | 
Patient and Physician Convenience and the Choice of Intravitreal Anti–Vascular Endothelial Growth Factor Medications
John T. Thompson, MD
JAMA Ophthalmology
Original Investigation  | 
Effect of Regulatory Requirement for Patient-Specific Prescriptions for Off-Label Medications on the Use of Intravitreal Bevacizumab
Steven Holfinger, MD; Alexander G. Miller; Llewelyn J. Rao, MD; et al.
JAMA Ophthalmology
Observation  | 
CRB1-Related Maculopathy With Cystoid Macular Edema
Yulia Wolfson, MD; Carolyn D. Applegate, MGC; Rupert W. Strauss, MD; et al.
JAMA Ophthalmology
Original Investigation  | 
Qualifying to Use a Home Monitoring Device for Detection of Neovascular Age-Related Macular Degeneration
Merina Thomas, MD; Yulia Wolfson, MD; Shiri Zayit-Soudry, MD; et al.